Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/21/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5046 publications
To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
Your chemo is no good here: management of high-risk MCL.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
T-cell-based therapies for treating relapsed or refractory mantle cell lymphoma.
Journal: Hematology. American Society of Hematology. Education Program
Published: December 07, 2024
Cost-effectiveness studies of brexu-cel for Relapsed/Refractory B-Cell acute lymphoblastic leukemia and Mantle Cell Lymphoma: a systematic review.
Journal: Expert review of pharmacoeconomics & outcomes research
Published: December 05, 2024
Ischemic Retinopathy Associated With Mantle Cell Lymphoma-Induced Vascular Occlusion.
Journal: Journal of vitreoretinal diseases
Published: November 15, 2024
Ibrutinib and venetoclax combination therapy for mantle cell lymphoma: are two better than one?
Journal: Expert review of hematology
Published: November 08, 2024
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort Study.
Journal: Cancers
Published: November 06, 2024
Extranodal Mantle Cell Lymphoma Presented as Bilateral Adrenal Masses on 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT.
Journal: Clinical nuclear medicine
Published: October 31, 2024
Matching-adjusted indirect comparison of Acalabrutinib versus Ibrutinib in relapsed/refractory mantle cell lymphoma.
Journal: Journal of medical economics
Published: October 26, 2024
Bilateral Intraocular Involvement of Recurrent Mantle Cell Lymphoma with Remission of Pseudo-Uveitis and Secondary Glaucoma After Switching Treatment to Ibrutinib: A Case Report.
Journal: Ocular immunology and inflammation
Published: October 25, 2024
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable.
Measurable Residual Disease in Mantle Cell Lymphoma: The Unbearable Lightness of Being Undetectable.
Journal: Current oncology reports
Published: October 23, 2024
Last Updated: 01/21/2025